What is it about?
To evaluate the quality and quantity of health economic research published until the end of 2017 in G.C.C.
Featured Image
Why is it important?
To date, there has been no analyses conducted of the economic evaluation studies emerging from G.C.C, and there is still little information about the health and pharmacy economics studies in the region. Also, the current economic downward due to a reduction in Oil`s price and increasing population in the region so, it is imperative to evaluate the studies that originate in this region, for quantity and quality, in order to make future recommendations for research and to ensure that the studies being utilized for decision-making for medicines and medical services are based on sound evidence
Perspectives
Read the Original
This page is a summary of: Evaluating quantity and quality of literature focusing on health economics and pharmacoeconomics in Gulf Cooperation Council countries, Expert Review of Pharmacoeconomics & Outcomes Research, May 2018, Taylor & Francis,
DOI: 10.1080/14737167.2018.1479254.
You can read the full text:
Contributors
The following have contributed to this page